Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2757-2768
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2757
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2757
Table 1 Collected tissue and plasma samples
Specimen type | Specimen origin | Specimen number |
Plasma | Patients with primary GC | 39 (female, 44-85 yr) |
61 (male, 42-85 yr) | ||
Healthy subjects | 100 (40-88 yr) | |
Preoperative and postoperative paired samples | 21 | |
Patients with benign gastric lesions | 15 | |
Patients with precancerous lesions | 15 | |
Tissue | Gastric cancer tissues | 20 |
Matching para-cancerous tissues | 20 |
Table 2 The intra-assay and inter-assay repeatability of circ_0004592 and 18S rRNA
Intra-assay | Inter-assay | |
mean ± SD, CV (%) | mean ± SD, CV (%) | |
Circ_0004592 | 23.23 ± 0.48, 2.06 | 24.01 ± 0.91, 3.79 |
18S rRNA | 15.32 ± 0.28, 1.83 | 14.87 ± 0.56, 3.77 |
Table 3 The correlation between circ_0004592 expression and clinicopathological parameters of gastric cancer patients
Characteristics | No. of patients | Low expression | High expression | P value |
Gender | ||||
Male | 61 | 33 | 28 | 0.206 |
Female | 39 | 17 | 22 | |
Age | ||||
≤ 60 | 34 | 14 | 20 | 0.146 |
> 60 | 66 | 36 | 30 | |
Tumor size, cm | ||||
< 5 | 72 | 36 | 36 | 0.176 |
≥ 5 | 28 | 14 | 14 | |
Pathological differentiation | ||||
Poor-undifferentiation | 59 | 22 | 37 | 0.002b |
Well-moderate | 41 | 28 | 13 | |
Tumor depth | ||||
T1-T2 | 50 | 32 | 18 | 0.004b |
T3-T4 | 50 | 18 | 32 | |
Lymph node metastasis | ||||
Yes | 49 | 19 | 30 | 0.022a |
No | 51 | 31 | 20 | |
Nerve/vascular invasion | ||||
Positive | 48 | 22 | 26 | 0.274 |
Negative | 52 | 28 | 24 | |
CEA | ||||
Positive | 60 | 36 | 24 | 0.012a |
Negative | 40 | 14 | 26 | |
CA199 | ||||
Positive | 51 | 25 | 26 | 0.500 |
Negative | 49 | 25 | 24 |
Table 4 The single or combination diagnosis of circ_0004592, carcinoembryonic antigen, and cancer antigen 199
SEN, % | SPE, % | ACCU, % | PPV, % | NPV, % | |
Circ_0004592 | 66.00 (66/100) | 84.00 (84/100) | 75.00 (150/200) | 80.49 (66/82) | 71.19 (84/118) |
CEA | 60.00 (60/100) | 77.00 (77/100) | 68.50 (137/200) | 72.29 (60/83) | 65.81 (77/117) |
CA199 | 51.00 (51/100) | 84.00 (84/100) | 67.50 (135/200) | 76.12 (51/67) | 63.16 (84/133) |
Circ_0004592 + CEA | 74.00 (74/100) | 76.00 (76/100) | 75.00 (150/200) | 75.51 (74/98) | 74.51 (76/102) |
Circ_0004592 + CA199 | 67.00 (67/100) | 88.00 (88/100) | 77.50 (155/200) | 84.81 (67/79) | 72.73 (88/121) |
Circ_0004592 + CEA + CA199 | 85.00 (85/100) | 65.00 (65/100) | 75.00 (150/200) | 70.83 (85/120) | 81.25 (65/80) |
- Citation: Kong S, Xu YH, Zheng M, Ju SQ, Shi HC. Circ_0004592: An auxiliary diagnostic biomarker for gastric cancer. World J Gastrointest Oncol 2024; 16(6): 2757-2768
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2757.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2757